Insmed Incorporated (INSM)

Insmed Inc. experienced significant selling activity over the past ninety days, totaling over $90 million. Executives and directors, including the CEO and COO, executed multiple planned divestments following a positive earnings report. These transactions occurred amidst a 30.6% stock price increase, reflecting broad leadership participation in liquidating equity positions.
Ticker: INSM Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Insmed Incorporated. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Brennan David R Non-Executive Director
Transaction date
Sale
Price
175.34
Quantity 71,482 -13.8%
Value US$433,450
1.9
Brennan David R Director Non-Executive Director
Transaction date
Proposed sale
Price
220.00
Quantity 86,595
Value US$1,077,148
1.9
Brennan David R Director Non-Executive Director
Transaction date
Proposed sale
Price
258.92
Quantity 41,153
Value US$627,473
3.6
SHAROKY MELVIN MD Non-Executive Director
Transaction date
Sale
Price
127.53
Quantity 5,000 -100.0%
Value US$637,650
3.6
MELVIN SHAROKY Director Non-Executive Director
Transaction date
Proposed sale
Price
127.53
Quantity 5,000
Value US$637,637
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
133.27
Quantity 239,850 -70.8%
Value US$31,964,810
2.9
Roger Adsett Officer Officer
Transaction date
Proposed sale
Price
133.26
Quantity 239,850
Value US$31,963,198
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
129.40
Quantity 18,278 -23.2%
Value US$2,365,173
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
127.00
Quantity 8,895 -10.1%
Value US$1,129,665
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
128.61
Quantity 27,173
Value US$3,494,755
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.43
Quantity 5,872 -2.2%
Value US$624,957
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
105.62
Quantity 4,828 -1.8%
Value US$509,933
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
106.06
Quantity 10,700
Value US$1,134,867
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
118.52
Quantity 3,359 -1.3%
Value US$398,109
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
117.62
Quantity 2,335 -0.9%
Value US$274,643
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
116.55
Quantity 5,005 -1.9%
Value US$583,333
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
117.40
Quantity 10,699
Value US$1,256,029
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
110.60
Quantity 7,448 -11.0%
Value US$823,749
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
109.02
Quantity 4,854 -6.7%
Value US$529,183
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
109.97
Quantity 12,302
Value US$1,352,864
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.27
Quantity 1,292 -0.5%
Value US$137,301
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
105.27
Quantity 2,456 -0.9%
Value US$258,543
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
104.28
Quantity 3,723 -1.4%
Value US$388,234
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
103.10
Quantity 1,836 -0.7%
Value US$189,292
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
102.34
Quantity 12,091 -4.3%
Value US$1,237,393
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
103.31
Quantity 21,398
Value US$2,210,653
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Planned sale
Price
95.82
Quantity 1,806 -4.6%
Value US$173,051
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
95.81
Quantity 1,806
Value US$173,039
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
95.81
Quantity 1,806
Value US$173,039
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
94.03
Quantity 6,515 -2.5%
Value US$612,605
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
94.03
Quantity 6,515
Value US$612,576
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
103.77
Quantity 1,858
Value US$192,811
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
103.77
Quantity 1,858
Value US$192,811
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
103.78
Quantity 1,858 -3.0%
Value US$192,823
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
103.78
Quantity 1,858 -3.0%
Value US$192,823
2.8
Bonstein Sara Chief Financial Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,404 -3.4%
Value US$245,857
2.8
Bonstein Sara Chief Financial Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,404 -3.4%
Value US$245,857
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,370 -2.3%
Value US$242,380
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,370 -2.3%
Value US$242,380
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,566 -4.0%
Value US$262,425
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,566 -4.0%
Value US$262,425
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,159 -5.2%
Value US$220,801
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,159 -5.2%
Value US$220,801
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Sale
Price
102.27
Quantity 7,605 -2.8%
Value US$777,763
2.8
Sara Bonstein Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,404
Value US$245,857
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,566
Value US$262,424
2.9
Roger Adsett Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,370
Value US$242,379
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,159
Value US$220,800
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 7,605
Value US$777,763
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
108.46
Quantity 6,149
Value US$666,951
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Planned sale
Price
108.47
Quantity 6,149 -12.9%
Value US$666,982
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.97
Quantity 7,975 -2.8%
Value US$853,086
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.39
Quantity 11,836 -4.0%
Value US$1,259,232
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
105.32
Quantity 5,753 -1.9%
Value US$605,906
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
106.33
Quantity 25,564
Value US$2,718,106
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
117.54
Quantity 10,479 -13.9%
Value US$1,231,702
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
117.53
Quantity 10,479
Value US$1,231,599
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Sale
Price
116.18
Quantity 4,109 -7.9%
Value US$477,384
2.8
Bonstein Sara Chief Financial Officer Officer
Transaction date
Sale
Price
116.18
Quantity 8,272 -10.4%
Value US$961,041
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Sale
Price
116.18
Quantity 13,283 -4.4%
Value US$1,543,219
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
116.18
Quantity 5,837 -5.5%
Value US$678,143
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
116.18
Quantity 3,384 -4.3%
Value US$393,153
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
112.76
Quantity 4,470 -5.4%
Value US$504,037
2.9
Roger Adsett Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 5,837
Value US$678,142
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 4,109
Value US$477,383
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
114.23
Quantity 7,854
Value US$897,145
2.8
Sara Bonstein Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 8,272
Value US$961,040
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 13,283
Value US$1,543,218
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
101.18
Quantity 830 -1.0%
Value US$83,979
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
100.35
Quantity 12,119 -12.6%
Value US$1,216,142
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
100.40
Quantity 12,949
Value US$1,300,105
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
139.60
Quantity 381 -0.1%
Value US$53,188
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
139.09
Quantity 1,247 -0.4%
Value US$173,445
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
137.86
Quantity 2,721 -0.9%
Value US$375,117
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
137.01
Quantity 5,318 -1.7%
Value US$728,619
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-11 2026-09-09 S Sale Non-Executive Director
71,482 -13.8%
175.34
US$433,450
71,482 -13.8% 175.34 US$433,450
2026-09-10 2026-09-09 PrS Proposed sale

Director

Non-Executive Director
86,595
220.00
US$1,077,148
86,595 220.00 US$1,077,148
2026-09-10 2026-09-09 PrS Proposed sale

Director

Non-Executive Director
41,153
258.92
US$627,473
41,153 258.92 US$627,473
2026-08-19 2026-08-17 S Sale Non-Executive Director
5,000 -100.0%
127.53
US$637,650
5,000 -100.0% 127.53 US$637,650
2026-08-17 2026-08-17 PrS Proposed sale

Director

Non-Executive Director
5,000
127.53
US$637,637
5,000 127.53 US$637,637
2026-08-12 2026-08-10 S Sale

Chief Operating Officer

Officer
239,850 -70.8%
133.27
US$31,964,810
239,850 -70.8% 133.27 US$31,964,810
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
239,850
133.26
US$31,963,198
239,850 133.26 US$31,963,198
2026-08-07 2026-08-06 PlS Planned sale

Chief Medical Officer

Officer
18,278 -23.2%
129.40
US$2,365,173
18,278 -23.2% 129.40 US$2,365,173
2026-08-07 2026-08-06 PlS Planned sale

Chief Medical Officer

Officer
8,895 -10.1%
127.00
US$1,129,665
8,895 -10.1% 127.00 US$1,129,665
2026-08-06 2026-08-06 PrS Proposed sale

Officer

Officer
27,173
128.61
US$3,494,755
27,173 128.61 US$3,494,755
2026-07-24 2026-07-23 PlS Planned sale

Chair and CEO

Executive Director
5,872 -2.2%
106.43
US$624,957
5,872 -2.2% 106.43 US$624,957
2026-07-24 2026-07-23 PlS Planned sale

Chair and CEO

Executive Director
4,828 -1.8%
105.62
US$509,933
4,828 -1.8% 105.62 US$509,933
2026-07-23 2026-07-23 PrS Proposed sale

Officer

Officer
10,700
106.06
US$1,134,867
10,700 106.06 US$1,134,867
2026-07-10 2026-07-09 PlS Planned sale

Chair and CEO

Executive Director
3,359 -1.3%
118.52
US$398,109
3,359 -1.3% 118.52 US$398,109
2026-07-10 2026-07-09 PlS Planned sale

Chair and CEO

Executive Director
2,335 -0.9%
117.62
US$274,643
2,335 -0.9% 117.62 US$274,643
2026-07-10 2026-07-09 PlS Planned sale

Chair and CEO

Executive Director
5,005 -1.9%
116.55
US$583,333
5,005 -1.9% 116.55 US$583,333
2026-07-09 2026-07-09 PrS Proposed sale

Officer

Officer
10,699
117.40
US$1,256,029
10,699 117.40 US$1,256,029
2026-07-08 2026-07-06 PlS Planned sale

Chief Medical Officer

Officer
7,448 -11.0%
110.60
US$823,749
7,448 -11.0% 110.60 US$823,749
2026-07-08 2026-07-06 PlS Planned sale

Chief Medical Officer

Officer
4,854 -6.7%
109.02
US$529,183
4,854 -6.7% 109.02 US$529,183
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
12,302
109.97
US$1,352,864
12,302 109.97 US$1,352,864
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
1,292 -0.5%
106.27
US$137,301
1,292 -0.5% 106.27 US$137,301
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
2,456 -0.9%
105.27
US$258,543
2,456 -0.9% 105.27 US$258,543
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
3,723 -1.4%
104.28
US$388,234
3,723 -1.4% 104.28 US$388,234
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
1,836 -0.7%
103.10
US$189,292
1,836 -0.7% 103.10 US$189,292
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
12,091 -4.3%
102.34
US$1,237,393
12,091 -4.3% 102.34 US$1,237,393
2026-06-25 2026-06-25 PrS Proposed sale

Officer

Officer
21,398
103.31
US$2,210,653
21,398 103.31 US$2,210,653
2026-06-24 2026-06-22 PlS Planned sale

Chief Legal Officer

Officer
1,806 -4.6%
95.82
US$173,051
1,806 -4.6% 95.82 US$173,051
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
1,806
95.81
US$173,039
1,806 95.81 US$173,039
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
1,806
95.81
US$173,039
1,806 95.81 US$173,039
2026-06-10 2026-06-08 PlS Planned sale

Chair and CEO

Executive Director
6,515 -2.5%
94.03
US$612,605
6,515 -2.5% 94.03 US$612,605
2026-06-08 2026-06-08 PrS Proposed sale

Officer

Officer
6,515
94.03
US$612,576
6,515 94.03 US$612,576
2026-06-05 2026-06-05 PrS Proposed sale

Officer

Officer
1,858
103.77
US$192,811
1,858 103.77 US$192,811
2026-06-05 2026-06-05 PrS Proposed sale

Officer

Officer
1,858
103.77
US$192,811
1,858 103.77 US$192,811
2026-06-05 2026-06-05 PlS Planned sale

Chief Medical Officer

Officer
1,858 -3.0%
103.78
US$192,823
1,858 -3.0% 103.78 US$192,823
2026-06-05 2026-06-05 PlS Planned sale

Chief Medical Officer

Officer
1,858 -3.0%
103.78
US$192,823
1,858 -3.0% 103.78 US$192,823
2026-06-05 2026-06-03 S Sale

Chief Financial Officer

Officer
2,404 -3.4%
102.27
US$245,857
2,404 -3.4% 102.27 US$245,857
2026-06-05 2026-06-03 S Sale

Chief Financial Officer

Officer
2,404 -3.4%
102.27
US$245,857
2,404 -3.4% 102.27 US$245,857
2026-06-05 2026-06-03 S Sale

Chief Operating Officer

Officer
2,370 -2.3%
102.27
US$242,380
2,370 -2.3% 102.27 US$242,380
2026-06-05 2026-06-03 S Sale

Chief Operating Officer

Officer
2,370 -2.3%
102.27
US$242,380
2,370 -2.3% 102.27 US$242,380
2026-06-05 2026-06-03 S Sale

Chief Medical Officer

Officer
2,566 -4.0%
102.27
US$262,425
2,566 -4.0% 102.27 US$262,425
2026-06-05 2026-06-03 S Sale

Chief Medical Officer

Officer
2,566 -4.0%
102.27
US$262,425
2,566 -4.0% 102.27 US$262,425
2026-06-05 2026-06-03 S Sale

Chief Legal Officer

Officer
2,159 -5.2%
102.27
US$220,801
2,159 -5.2% 102.27 US$220,801
2026-06-05 2026-06-03 S Sale

Chief Legal Officer

Officer
2,159 -5.2%
102.27
US$220,801
2,159 -5.2% 102.27 US$220,801
2026-06-05 2026-06-03 S Sale

Chair and CEO

Executive Director
7,605 -2.8%
102.27
US$777,763
7,605 -2.8% 102.27 US$777,763
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,404
102.27
US$245,857
2,404 102.27 US$245,857
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,566
102.27
US$262,424
2,566 102.27 US$262,424
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,370
102.27
US$242,379
2,370 102.27 US$242,379
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,159
102.27
US$220,800
2,159 102.27 US$220,800
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
7,605
102.27
US$777,763
7,605 102.27 US$777,763
2026-05-22 2026-05-22 PrS Proposed sale

Officer

Officer
6,149
108.46
US$666,951
6,149 108.46 US$666,951
2026-05-22 2026-05-22 PlS Planned sale

Chief Legal Officer

Officer
6,149 -12.9%
108.47
US$666,982
6,149 -12.9% 108.47 US$666,982
2026-05-20 2026-05-18 PlS Planned sale

Chair and CEO

Executive Director
7,975 -2.8%
106.97
US$853,086
7,975 -2.8% 106.97 US$853,086
2026-05-20 2026-05-18 PlS Planned sale

Chair and CEO

Executive Director
11,836 -4.0%
106.39
US$1,259,232
11,836 -4.0% 106.39 US$1,259,232
2026-05-20 2026-05-18 PlS Planned sale

Chair and CEO

Executive Director
5,753 -1.9%
105.32
US$605,906
5,753 -1.9% 105.32 US$605,906
2026-05-18 2026-05-18 PrS Proposed sale

Officer

Officer
25,564
106.33
US$2,718,106
25,564 106.33 US$2,718,106
2026-05-15 2026-05-14 PlS Planned sale

Chief Medical Officer

Officer
10,479 -13.9%
117.54
US$1,231,702
10,479 -13.9% 117.54 US$1,231,702
2026-05-14 2026-05-14 PrS Proposed sale

Officer

Officer
10,479
117.53
US$1,231,599
10,479 117.53 US$1,231,599
2026-05-15 2026-05-13 S Sale

Chief Legal Officer

Officer
4,109 -7.9%
116.18
US$477,384
4,109 -7.9% 116.18 US$477,384
2026-05-15 2026-05-13 S Sale

Chief Financial Officer

Officer
8,272 -10.4%
116.18
US$961,041
8,272 -10.4% 116.18 US$961,041
2026-05-15 2026-05-13 S Sale

Chair and CEO

Executive Director
13,283 -4.4%
116.18
US$1,543,219
13,283 -4.4% 116.18 US$1,543,219
2026-05-15 2026-05-13 S Sale

Chief Operating Officer

Officer
5,837 -5.5%
116.18
US$678,143
5,837 -5.5% 116.18 US$678,143
2026-05-15 2026-05-13 S Sale

Chief Medical Officer

Officer
3,384 -4.3%
116.18
US$393,153
3,384 -4.3% 116.18 US$393,153
2026-05-15 2026-05-13 S Sale

Chief Medical Officer

Officer
4,470 -5.4%
112.76
US$504,037
4,470 -5.4% 112.76 US$504,037
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
5,837
116.18
US$678,142
5,837 116.18 US$678,142
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
4,109
116.18
US$477,383
4,109 116.18 US$477,383
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
7,854
114.23
US$897,145
7,854 114.23 US$897,145
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
8,272
116.18
US$961,040
8,272 116.18 US$961,040
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
13,283
116.18
US$1,543,218
13,283 116.18 US$1,543,218
2026-05-13 2026-05-11 PlS Planned sale

Chief Medical Officer

Officer
830 -1.0%
101.18
US$83,979
830 -1.0% 101.18 US$83,979
2026-05-13 2026-05-11 PlS Planned sale

Chief Medical Officer

Officer
12,119 -12.6%
100.35
US$1,216,142
12,119 -12.6% 100.35 US$1,216,142
2026-05-11 2026-05-11 PrS Proposed sale

Officer

Officer
12,949
100.40
US$1,300,105
12,949 100.40 US$1,300,105
2026-05-06 2026-05-04 PlS Planned sale

Chair and CEO

Executive Director
381 -0.1%
139.60
US$53,188
381 -0.1% 139.60 US$53,188
2026-05-06 2026-05-04 PlS Planned sale

Chair and CEO

Executive Director
1,247 -0.4%
139.09
US$173,445
1,247 -0.4% 139.09 US$173,445
2026-05-06 2026-05-04 PlS Planned sale

Chair and CEO

Executive Director
2,721 -0.9%
137.86
US$375,117
2,721 -0.9% 137.86 US$375,117
2026-05-06 2026-05-04 PlS Planned sale

Chair and CEO

Executive Director
5,318 -1.7%
137.01
US$728,619
5,318 -1.7% 137.01 US$728,619